Expression of CD151 in EOC tumors, the known involvement of CD151 in cell migration and invasion, and the in vivo ability of αCD151 antibody to contain breast cancer tumors to single nodules and eliminate tumor spread suggested that CD151 may also represent a promising and relevant candidate for therapeutic targeting in ovarian cancer. This evidence concerns the gene CD151 and breast cancer.